Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Neil Kumar > Profile

Neil Kumar

Affiliations

  • Chief Executive Officer at Bridgebio Pharma Inc. (BBIO), 2025-01-30
  • Director at Lianbio (LIAN), 2021-11-09
  • Chief Executive Officer at Eidos Therapeutics Inc. (EIDX), 2019-07-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Eidos Therapeutics Inc.
 EIDX $29.90 882,353 Large Shareholder, Officer, Director 24,575,501 2019-07-03 Filing
Eidos Therapeutics Inc.
 EIDX $25.93 1,103,848 Large Shareholder, Officer, Director 23,693,148 2019-05-24 Filing
Eidos Therapeutics Inc.
 EIDX $13.96 2,664 Large Shareholder, Officer, Director 22,589,300 2018-12-10 Filing
Eidos Therapeutics Inc.
 EIDX $13.29 37,989 Large Shareholder, Officer, Director 22,586,636 2018-12-10 Filing
Eidos Therapeutics Inc.
 EIDX $14.36 4,860 Large Shareholder, Officer, Director 22,548,647 2018-12-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Bridgebio Pharma Inc.
 BBIO $36.82 4,000 5,098,447 2025-01-29 Filing
Bridgebio Pharma Inc.
 BBIO $36.34 269,068 5,102,447 2025-01-29 Filing
Bridgebio Pharma Inc.
 BBIO $36.29 326,932 5,371,515 2025-01-28 Filing
Bridgebio Pharma Inc.
 BBIO $22.76 1,875 4,897,443 2024-11-19 Filing
Bridgebio Pharma Inc.
 BBIO $22.39 25,514 4,899,318 2024-11-19 Filing